Showing 3,321 - 3,340 results of 5,085 for search '"cardiovascular"', query time: 0.06s Refine Results
  1. 3321
  2. 3322
  3. 3323

    Role of PPARα and Its Agonist in Renal Diseases by Ching-Feng Cheng, Hsi-Hsien Chen, Heng Lin

    Published 2010-01-01
    “…In clinical application, PPAR-α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. This paper focuses on signaling pathways, ligand selectivity, and physio-pathological roles of PPARα in kidney diseases and the therapeutic utility of PPARα modulators in the treatment of diabetes and inflammation-induced nephropathy. …”
    Get full text
    Article
  4. 3324

    Nano Delivery System for Atherosclerosis by Zhuoyi Rong, Xuan He, Tianjian Fan, Haitao Zhang

    Published 2024-12-01
    “…Atherosclerosis, a pathological process propelled by inflammatory mediators and lipids, is a principal contributor to cardiovascular disease incidents. Currently, drug therapy, the primary therapeutic strategy for atherosclerosis, faces challenges such as poor stability and significant side effects. …”
    Get full text
    Article
  5. 3325

    Provide a method to diagnose and optimize diabetes using data mining methods and firefly algorithm by Reza Molaee Fard

    Published 2023-09-01
    “…The use of data mining methods can help in the early diagnosis of diabetes, which prevents the progression of this disease and many of its complications such as cardiovascular disease, vision problems and kidney disease. …”
    Get full text
    Article
  6. 3326

    Clinical approach to palpitations in pregnancy by Ferha Saeed, Kirun Gunganah, Anna S. Herrey

    Published 2025-01-01
    “…Patients with structural or functional abnormalities or inherited cardiovascular disease are more likely to develop arrhythmia, especially during pregnancy when the mother’s body undergoes extensive physiological adaptations, which further contribute to an increased arrhythmia risk. …”
    Get full text
    Article
  7. 3327

    Metformin: A Possible Option in Cancer Chemotherapy by Chidiebere V. Ugwueze, Odunze J. Ogamba, Ekenechukwu E. Young, Belonwu M. Onyenekwe, Basil C. Ezeokpo

    Published 2020-01-01
    “…The drug came into prominence in diabetes and other conditions with cardiovascular risk after the landmark study of 1995 by the United Kingdom Prospective Diabetes Study which emphasized its importance. …”
    Get full text
    Article
  8. 3328
  9. 3329

    Physical Activity: Exploring Views of Older Russian-Speaking Slavic Immigrants by Janet Purath, Catherine Van Son, Cynthia F. Corbett

    Published 2011-01-01
    “…Many of the 1.3 million Russian-speaking immigrants in the US have chronic conditions such as cardiovascular disease, diabetes, obesity, and depression. …”
    Get full text
    Article
  10. 3330

    Cardiac regeneration: 20 years of development and update in zebrafish and mouse by Lekun Gui, Lijun Jin, Huangjun Liu

    Published 2024-12-01
    “…Cardiovascular diseases are one of the leading causes of death globally. …”
    Get full text
    Article
  11. 3331
  12. 3332

    Metastatic Calcinosis of Aortic Valve Secondary to Renal Failure Mimicking Infective Endocarditis by Noman Ahmed Jang Khan, Masroor A. Khan, Guillermo Juan Morell Chardon

    Published 2016-01-01
    “…End stage renal disease has a list of consequences, cardiovascular being the most common. Inefficient dialysis can cause significant deposition of calcium all over the body, including heart valves making heart function impaired. …”
    Get full text
    Article
  13. 3333

    Acorn Oil: Chemistry and Functionality by Mehdi Taib, Lahboub Bouyazza, Badiaa Lyoussi

    Published 2020-01-01
    “…Diets enriched with acorn oil can be beneficial in preventing cardiovascular disease (CVD), cancer, and type 2 diabetes as well as offer antioxidant activity. …”
    Get full text
    Article
  14. 3334
  15. 3335

    Sarcopenia: A Major Challenge in Elderly Patients with End-Stage Renal Disease by Maciej Domański, Kazimierz Ciechanowski

    Published 2012-01-01
    “…If it cannot be treated with the simple methods requiring some knowledge and devotion, we will fail to save patients who die due to cardiovascular disease and infection, despite proper conduction of renal replacement therapy. …”
    Get full text
    Article
  16. 3336

    Ascending to descending aortic prosthesis with reimplantation of brachiocephalic vessels in aneurysm of the arch and descending aorta for hypoplasia of the arch and coarctation of... by B.M. Todurov, O.V. Zelenchuk, S.M. Sudakevych, A.Yu. Shkandala, N.S. Gnoyanko

    Published 2020-06-01
    “…Thoracic aortic aneurysm is one of the most serious pathologies of cardiovascular surgery. Occurrence of an aneurysm in the proximal or distal part of the aortic arch is a recognized complication of uncorrected aortic coarctation and is associated with a significant risk of aortic rupture. …”
    Get full text
    Article
  17. 3337

    Brown fat thermogenesis and branched-chain amino acids in metabolic disease by Zachary Brown, Takeshi Yoneshiro

    Published 2024-02-01
    “…The newly identified MBC offers new therapeutic avenues by which BAT activity may be enhanced to improve metabolic and cardiovascular health, as well as other diseases in which increases of circulating BCAA may play a role in pathogenicity.…”
    Get full text
    Article
  18. 3338
  19. 3339

    Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes by Zijun Ma, Kaiqin Jin, Mengmeng Yue, Xin Chen, Jun Chen

    Published 2023-01-01
    “…Its hypoglycaemic and weight loss effects have been demonstrated in several large clinical trials, and there is also evidence that it has great potential for cardiovascular protection. In addition, the very concept of synthetic peptides opens up many unknown possibilities for tirzepatide. …”
    Get full text
    Article
  20. 3340

    Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing by Gopi Krishna Kolluru, Shyamal C. Bir, Christopher G. Kevil

    Published 2012-01-01
    “…Many experimental studies have identified better approaches for diabetic cardiovascular complications, however, successful clinical translation has been limited possibly due to the narrow therapeutic targets of these agents or the lack of rigorous evaluation of pathology and therapeutic mechanisms in experimental models of disease. …”
    Get full text
    Article